PEG-MGF
Also known as: Pegylated Mechano Growth Factor, IGF-1 Splice Variant
Primary recreational use: Muscle Repair and Recovery
What is PEG-MGF?
PEG-MGF (Pegylated Mechano Growth Factor) is a modified form of the IGF-1 splice variant MGF, designed to extend its half-life from minutes to hours. It is primarily used in research for muscle repair and regeneration, as well as neuroprotection. While promising in vitro and animal studies exist, PEG-MGF is not FDA-approved and is classified as a research chemical. Key risks include the potential for cellular changes and contraindications, especially in those with a history of cancer.
Primary Benefits
Promotes muscle repair and regeneration. Supports recovery from injury. Potential neuroprotective effects.
How It Works
PEG-MGF works by activating muscle satellite (stem) cells through the MAPK/ERK signaling pathway. By binding to specific receptors, it enhances protein synthesis and muscle fiber repair. The PEGylation increases its half-life, allowing prolonged biological activity compared to unmodified MGF.
Safety Tips
Precautions reported in community discussions and literature. This is not a complete list.
- 1.DON'T start with a high dose - begin with the lowest effective dose.
- 2.DON'T use if you have a history of cancer or neoplastic disease.
- 3.AVOID using during pregnancy or while breastfeeding.
- 4.DON'T inject near the injection site of insulin without monitoring blood glucose.
- 5.AVOID freezing reconstituted solution - store in refrigerator.
Use Contexts
Different purposes have different protocols, dosing, and considerations
Muscle Repair
strong evidenceUsed to promote muscle repair and enhance recovery from training or injury.
Evidence: Supported by human cell studies and multiple animal model experiments.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
Timing: Post-workout
Notes: Optimal when administered near damaged muscles for targeted effects.
Community-Reported Protocols
Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| General Recovery Protocol | 200mcg | 2-3 times weekly | Subcutaneous or intramuscular |
| Targeted Muscle Recovery | 200-400mcg | Post-workout, 2-3 times weekly | Intramuscular |
| Injury Recovery Protocol | 200-400mcg | 2-3 times weekly | Intramuscular near injury site |
| Conservative Research Protocol | 100-200mcg | 2 times weekly | Subcutaneous |
Pharmacokinetics
Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
Serious / Rare
- Unusual growths or lumps
- Rapid changes in blood glucose levels
Injection-Specific Warnings
- Injection site reactions such as redness or swelling
- Ensure sterile technique to prevent infections
Storage
Harm Reduction Information
Quality Concerns
- Potential contamination from unregulated sources
- Mislabeling of product or concentration
- Degradation if not stored correctly
Safety Tips
- Use sterile technique during reconstitution and injection
- Rotate injection sites to avoid tissue damage
- Start with lower doses to assess individual tolerance
Warning Signs to Stop
- Occurrence of unusual growths or lumps
- Severe or prolonged injection site reactions
Seek Medical Help Immediately If
- Rapid changes in blood glucose not manageable at home
- Signs of infection at injection site
Frequently Asked Questions
Common questions about PEG-MGF
How long until I see effects?
With PEG-MGF, recovery benefits may begin to appear within 2-4 weeks, with optimal results around 6-8 weeks of consistent use.
What time of day should I take it?
PEG-MGF is best administered post-workout to align with natural MGF upregulation patterns, aiding muscle recovery.
How can I minimize side effects?
To minimize side effects when using PEG-MGF, start with a conservative dose, monitor blood glucose levels if diabetic, and consult with a healthcare provider if unsure.
Does tolerance develop?
PEG-MGF may lead to receptor desensitization, so it's recommended to take 4-8 weeks off between cycles to prevent this.
How should I store it?
Store PEG-MGF lyophilized at room temperature and reconstituted in the refrigerator at 2-8°C, protected from light.
Do I need to cycle it?
Yes, cycling PEG-MGF with 4-8 week on/off periods is recommended to maintain effectiveness and prevent tolerance.
Reported Combinations
Compounds reported to be used alongside PEG-MGF in community discussions
BPC-157
Synergizes for enhanced muscle repair and healing.
TB-500
Supports tissue repair and angiogenesis, complementing PEG-MGF effects.
CJC-1295/Ipamorelin
May enhance muscle growth and recovery.
IGF-1 LR3
Potential for enhanced anabolic effects, use caution.
MK-677
Growth hormone secretagogue that may support similar goals.
Resistance training
Exercise synergizes with PEG-MGF for muscle growth and recovery.
Reported Interactions
Interactions reported in literature and community discussions.
May alter blood glucose management, requiring monitoring.
May have additive effects on muscle growth and recovery.
Generally safe, but monitor for unusual side effects.
Generally safe and can be beneficial alongside PEG-MGF.
Safe and may support overall health when using PEG-MGF.
Reconstitution Calculator
100 units = 1 mL
Safety Tips
- Always consult a licensed medical professional for dosing and reconstitution instructions.
- Always double check your units. Mixing up mg and mcg can be very dangerous.
- Make sure to select your syringe type. U-100 and U-50 syringes have different units.
- Ensure you're not adding more BAC than your vial can hold. Most vials have maximum capacities listed.
This calculator is for informational and educational purposes only. It does not provide medical advice, dosing recommendations, or safety determinations. Reference ranges shown are compiled from publicly available sources and are not a substitute for guidance from a licensed healthcare professional.
Legal Status by Region
Regulatory status varies by country
USA
research chemical
UK
research chemical
EU
research chemical
Australia
research chemical
Canada
research chemical
Explore More Research
Browse our database of peptide research information compiled from published literature and community sources.
Citations
Last updated: October 5, 2023